Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 6/2009

01.11.2009 | Original Article

Differential effect of age, gender and puberty on bone formation rate assessed by measurement of bone-specific alkaline phosphatase in healthy Italian children and adolescents

verfasst von: Stefano Mora, Laura Cafarelli, Paola Erba, Maria Puzzovio, Ilaria Zamproni, Vania Giacomet, Alessandra Viganò

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Bones undergo intensive modeling during growth, a process involving both formation and resorption processes. Bone formation can be accurately monitored by measurements of bone-specific alkaline phosphatase (BAP) in serum. The lack of appropriate reference values has hampered the use of BAP in pediatric subjects. The purposes of the present study were to verify the effect of age, gender, and puberty on BAP concentration in healthy children, and to generate reference curves. Morning blood samples were collected from 239 healthy children and adolescents (113 boys), aged 4.5–20.9 years. Anthropometric measurements and pubertal stage were recorded. Blood samples were also obtained from 37 healthy young adults (13 men), aged 21.5–30.2 years. BAP concentration varied significantly with age, showing a peak at age 10–12 years in girls and 12–14 years in boys. Prepubertal concentration of BAP was six- to sevenfold higher than in healthy adults. We observed significantly higher BAP values at the beginning of puberty (stage II) compared to prepubertal stage in both sexes. The effect of puberty was independent from age and gender. We demonstrated that BAP serum concentration varies with age in children and adolescents, and we provided equations to calculate reference values. Because BAP concentrations vary markedly according to the pubertal stage, the values of BAP obtained in single patients should be compared to reference considering not only age and sex, but also the stage of pubertal development.
Literatur
1.
Zurück zum Zitat Mora S, Gilsanz V (2003) Establishment of peak bone mass. Endocrinol Metab Clin N Am 32:39–63CrossRef Mora S, Gilsanz V (2003) Establishment of peak bone mass. Endocrinol Metab Clin N Am 32:39–63CrossRef
2.
Zurück zum Zitat Rauch F (2005) Bone growth in length and width: the Yin and Yang of bone stability. J Muskoloskelet Neuronal Interact 5:194–201 Rauch F (2005) Bone growth in length and width: the Yin and Yang of bone stability. J Muskoloskelet Neuronal Interact 5:194–201
3.
Zurück zum Zitat Karsentry G, Kronenberg HM (2003) Postnatal bone growth: growth plate biology, modeling, and remodeling. In: Glorieux FH, Pettifor JM, Jüppner H (eds) Pediatric bone. Biology and disease. Academic Press, San Diego, pp 119–133 Karsentry G, Kronenberg HM (2003) Postnatal bone growth: growth plate biology, modeling, and remodeling. In: Glorieux FH, Pettifor JM, Jüppner H (eds) Pediatric bone. Biology and disease. Academic Press, San Diego, pp 119–133
4.
Zurück zum Zitat Rauch F (2006) Geometric strength: bone size during skeletal development. Curr Opin Endocrionol Diabetes 13:10–14CrossRef Rauch F (2006) Geometric strength: bone size during skeletal development. Curr Opin Endocrionol Diabetes 13:10–14CrossRef
5.
Zurück zum Zitat Shönau E, Rauch F (2003) Biochemical markers of bone metabolism. In: Glorieux FH, Pettifor JM, Jüppner H (eds) Pediatric bone. Biology and disease. Academic Press, San Diego, pp 339–357 Shönau E, Rauch F (2003) Biochemical markers of bone metabolism. In: Glorieux FH, Pettifor JM, Jüppner H (eds) Pediatric bone. Biology and disease. Academic Press, San Diego, pp 339–357
6.
Zurück zum Zitat Baroncelli I, Bertelloni S, Ceccarelli C, Cupelli D, Saggese G (2000) Dynamics of bone turnover in children with GH deficiency treated with GH until final height. Eur J Endocrinol 142:549–556CrossRefPubMed Baroncelli I, Bertelloni S, Ceccarelli C, Cupelli D, Saggese G (2000) Dynamics of bone turnover in children with GH deficiency treated with GH until final height. Eur J Endocrinol 142:549–556CrossRefPubMed
7.
Zurück zum Zitat Mora S, Barera G (2004) Bone mass and bone metabolism in pediatric gastrointestinal disorders. J Pediatr Gastroenterol Nutr 39:129–140CrossRefPubMed Mora S, Barera G (2004) Bone mass and bone metabolism in pediatric gastrointestinal disorders. J Pediatr Gastroenterol Nutr 39:129–140CrossRefPubMed
8.
Zurück zum Zitat Leonard MB (2007) Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 119:S166–S174CrossRefPubMed Leonard MB (2007) Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 119:S166–S174CrossRefPubMed
9.
Zurück zum Zitat Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593PubMed Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593PubMed
10.
Zurück zum Zitat Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child 51:170–179CrossRefPubMed Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child 51:170–179CrossRefPubMed
11.
Zurück zum Zitat Camozzi V, Tossi A, Simoni E, Pagani F, Francucci CM, Moro L (2007) Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 30:13–17PubMed Camozzi V, Tossi A, Simoni E, Pagani F, Francucci CM, Moro L (2007) Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 30:13–17PubMed
12.
Zurück zum Zitat Banfi G, Daverio R (1994) In vitro stability of osteocalcin. Clin Chem 40:883–884 Banfi G, Daverio R (1994) In vitro stability of osteocalcin. Clin Chem 40:883–884
13.
Zurück zum Zitat Posen S, Grunstein HS (1982) Turnover rate of skeletal alkaline phosphatase in humans. Clin Chem 28:153–154PubMed Posen S, Grunstein HS (1982) Turnover rate of skeletal alkaline phosphatase in humans. Clin Chem 28:153–154PubMed
14.
Zurück zum Zitat Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, Tanaka H, Seino Y (1997) Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Meta 82:2056–2061CrossRef Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, Tanaka H, Seino Y (1997) Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Meta 82:2056–2061CrossRef
15.
Zurück zum Zitat Kanbur NÖ, Derman O, Kmik E (2005) The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents. J Bone Miner Metab 23:76–83CrossRefPubMed Kanbur NÖ, Derman O, Kmik E (2005) The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents. J Bone Miner Metab 23:76–83CrossRefPubMed
16.
Zurück zum Zitat Mora S, Prinster C, Proverbio MC, Bellini A, de Poli SC, Weber G, Abbiati G, Chiumello G (1998) Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 63:369–374CrossRefPubMed Mora S, Prinster C, Proverbio MC, Bellini A, de Poli SC, Weber G, Abbiati G, Chiumello G (1998) Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 63:369–374CrossRefPubMed
17.
Zurück zum Zitat Tsai K-S, Jang M-H, Hsu SH-J, Cheng W-C, Chang M-H (1999) Bone alkaline phosphatase isoenzyme and carboxy-terminal propeptide of type-I procollagen in healthy Chinese girls and boys. Clin Chem 45:136–138PubMed Tsai K-S, Jang M-H, Hsu SH-J, Cheng W-C, Chang M-H (1999) Bone alkaline phosphatase isoenzyme and carboxy-terminal propeptide of type-I procollagen in healthy Chinese girls and boys. Clin Chem 45:136–138PubMed
18.
Zurück zum Zitat Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 92:443–449CrossRefPubMed Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 92:443–449CrossRefPubMed
Metadaten
Titel
Differential effect of age, gender and puberty on bone formation rate assessed by measurement of bone-specific alkaline phosphatase in healthy Italian children and adolescents
verfasst von
Stefano Mora
Laura Cafarelli
Paola Erba
Maria Puzzovio
Ilaria Zamproni
Vania Giacomet
Alessandra Viganò
Publikationsdatum
01.11.2009
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 6/2009
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-009-0092-4

Weitere Artikel der Ausgabe 6/2009

Journal of Bone and Mineral Metabolism 6/2009 Zur Ausgabe

List of Reviewers 2008-2009

List of Reviewers 2008–2009

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.